Even Holth Rustad
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 22
- Acute Myeloid Leukemia Research 3
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Ola Landgren (11 shared papers)Francesco Maura (9 shared papers)Niccolò Bolli (5 shared papers)Gareth John Morgan (5 shared papers)Malin L. Hultcrantz (5 shared papers)Kylee H. Maclachlan (5 shared papers)Benjamin T. Diamond (4 shared papers)Eileen Mary Boyle (3 shared papers)
- Journals
- Blood (4 papers)JAMA Oncology (3 papers)Leukemia (3 papers)Best Practice & Research Clinical Haematology (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- United StatesNorwayItaly
In The Last Decade
Even Holth Rustad
30 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 54
- Hematology 692
- Oncology 338
- Physiology 58
- Genetics 89
- Molecular Biology 535
Countries citing papers authored by Even Holth Rustad
This map shows the geographic impact of Even Holth Rustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even Holth Rustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even Holth Rustad more than expected).
Fields of papers citing papers by Even Holth Rustad
This network shows the impact of papers produced by Even Holth Rustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even Holth Rustad. The network helps show where Even Holth Rustad may publish in the future.
Co-authors
The 25 scholars most cited alongside Even Holth Rustad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 109 | |
| 2 | 2021 | 89 | |
| 3 | 2021 | 88 | |
| 4 | 2021 | 76 | |
| 5 | 2019 | 69 | |
| 6 | 2020 | 62 | |
| 7 | 2020 | 46 | |
| 8 | 2022 | 44 | |
| 9 | 2019 | 41 | |
| 10 | 2021 | 40 | |
| 11 | 2019 | 37 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 31 | |
| 14 | 2023 | 31 | |
| 15 | 2022 | 28 | |
| 16 | 2023 | 28 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2018 | 21 |
About Even Holth Rustad
Even Holth Rustad is a scholar working on Hematology, Cancer Research, Oncology, Molecular Biology and Immunology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (11 papers), Cancer Genomics and Diagnostics (6 papers), CAR-T cell therapy research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Cancer therapeutics and mechanisms (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Hematology (692 citations), Oncology (338 citations), Physiology (58 citations), Genetics (89 citations) and Molecular Biology (535 citations). Even Holth Rustad has collaborated with scholars based in United States, Norway and Italy. Frequent co-authors include Ola Landgren, Francesco Maura, Niccolò Bolli, Gareth John Morgan, Malin L. Hultcrantz, Kylee H. Maclachlan, Benjamin T. Diamond, Eileen Mary Boyle, Bachisio Ziccheddu and Venkata D. Yellapantula. Their work appears in journals such as Blood, JAMA Oncology, Leukemia, Best Practice & Research Clinical Haematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.